Pheochromocytoma: recent experience with detection and management

Area of Science:

• Endocrinology
• Oncology
• Surgical Pathology

Background:

• Pheochromocytoma is a rare neuroendocrine tumor.
• Accurate diagnosis relies on biochemical testing, such as metanephrine levels.
• False positive results can lead to unnecessary investigations and patient anxiety.

Purpose of the Study:

• To review a decade of experience with pheochromocytoma.
• To analyze the incidence and causes of false positive metanephrine excretion tests.
• To present the clinical course and outcomes of patients with resected pheochromocytomas.

Main Methods:

• Retrospective review of patient data over a ten-year period.
• Analysis of 1,890 metanephrine excretion level tests.
• Detailed examination of 15 surgically resected pheochromocytomas.

Main Results:

• Elevated metanephrine levels were found in 91 of 1,890 tests.
• An overall incidence of 1.9% false positive studies was identified.
• Clinical presentation, diagnostic methods, localization techniques, and surgical outcomes for 14 patients with 15 pheochromocytomas are presented.

Conclusions:

• Metanephrine testing for pheochromocytoma has a low false positive rate.
• Understanding factors contributing to false positives is crucial for accurate diagnosis.
• Comprehensive management, from diagnosis to surgery, is key to successful pheochromocytoma treatment.